首页|舒肺压方单煎与合煎的成分差异及对肺动脉高压的影响

舒肺压方单煎与合煎的成分差异及对肺动脉高压的影响

扫码查看
目的:探讨舒肺压方单煎、合煎成分特征及对肺动脉高压的改善作用。方法:通过超高效液相色谱-质谱法(UPLC-MS/MS)对舒肺压方单煎及合煎的成分进行定性、定量分析,明确不同煎煮法对舒肺压方成分特征的影响,并基于野百合碱诱导的大鼠肺动脉高压,观察舒肺压方单煎及合煎对肺动脉高压的改善作用。结果:舒肺压方单煎液及合煎液中均检出 707 种成分,单煎液与合煎液成分种类一致;其中 644种成分含量无明显差异,63 种成分含量具有显著差异;与单煎液比较,合煎液中有 46 种成分含量明显上调,17种成分含量明显下调;舒肺压方合煎较单煎可明显降低大鼠平均肺动脉压,改善肺部组织病理学损伤。结论:舒肺压方不同煎煮方式可影响其成分特征,合煎较单煎对野百合碱诱导的大鼠肺动脉高压的改善作用更显著。
Effects of Shufeiya Decoction on Pulmonary Hypertension
Objective:To investigate the effects of Shufeiya single decoction and combined decoction on pulmonary hypertension.Methods:Qualitative and quantitative analyses of the components of Shufeiya decoction were performed by UPLC-MS/MS to clarify the effects of Shufeiya decoction different decoction methods on monocrotaline-induced pulmonary hypertension in rats.Results:Seven hundred and seven ingredients were detected in both Shufeiya single decoction and combined decoction,and the composition types of them were the same.The contents of 644 ingredients were not significantly different and the contents of 63 ingredients were significantly different.Compared with single decoction,the contents of 46 ingredients were significantly up-regulated and 17 ingredients were significantly down-regulated in combined decoction.Shufeiya combined decoction significantly reduced the mean pulmonary artery of pulmonary hypertension rats compared with that by single decoction,and combined decoction could significantly improved the histopathological damage of lung compared with the single decoction.Conclusion:Different decoction methods of Shufeiya decoction can affect the composition characteristics,and the combined decoction shows more significant effect on the improvement of pulmonary hypertension induced by monocrotaline in rats than that by the single decoction.

pulmonary hypertensionShufeiya decoctionsingle decoctioncombined decoctionpharmacodynamic material basis

贾壮壮、王贤良、毛静远、王帅、曹雅雯、王琳、张泽宇、王慈

展开 >

天津中医药大学第一附属医院,国家中医针灸临床医学研究中心(天津 300381)

天津中医药大学

肺动脉高压 舒肺压方 单煎 合煎 药效物质基础

国家中医药局中医药创新团队及人才支持计划(2022)天津市卫生健康委(天津市中医药局)中医中西医结合科研项目

ZYYCXTD-C-2022032021048

2024

中西医结合心脑血管病杂志
中国中西医结合学会 山西医科大学第一医院

中西医结合心脑血管病杂志

CSTPCD
影响因子:1.463
ISSN:1672-1349
年,卷(期):2024.22(12)